HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prediction of IVIG treatment efficiency in fetal/neonatal alloimmune thrombocytopenia.

AuthorsGérald Bertrand, Rachel Petermann, Cécile Kaplan
JournalBlood (Blood) Vol. 124 Issue 4 Pg. 654-5 (Jul 24 2014) ISSN: 1528-0020 [Electronic] United States
PMID25061171 (Publication Type: Letter)
Chemical References
  • Immunoglobulins, Intravenous
Topics
  • Female
  • Fetal Diseases (immunology, prevention & control)
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Infant, Newborn
  • Infant, Newborn, Diseases (immunology, prevention & control)
  • Pregnancy
  • Prognosis
  • Prospective Studies
  • Thrombocytopenia, Neonatal Alloimmune (immunology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: